On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading
For journalists writing about march-in rights today, this is how it works. If you get money from the federal government for the R&D leading to an invention, there is typically a contract that gives the funder certain rights in any… Continue Reading
KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading
On Monday, 27 November 2023, Brazil delivered the following general statement at WIPO’s Thirty-First Session of the Committee on Development and Intellectual Property. The statement was delivered by Ambassador Guilherme Patriota, one of the architects of WIPO’s Development Agenda. General… Continue Reading
On November 3, 2023, Knowledge Ecology International (KEI) and Public Citizen (PC) submitted joint comments to the National Institutes of Health (NIH) regarding the “Prospective Grant of Exclusive Patent Commercialization License: Human Monoclonal Antibodies That Broadly Target Coronaviruses” (88 FR… Continue Reading
INB 7 Written statement by Knowledge Ecology International November 2023 The current draft of the pandemic accord includes provisions on limitations and exceptions to intellectual property rights that while well intentioned, are problematic. Parties do not need to refer to… Continue Reading
On Monday afternoon, 6 November 2023, Knowledge Ecology International (KEI) delivered the following oral statement (in person) at the 7th meeting of the World Health Organization’s (WHO) Intergovernmental Negotiating Body (INB). INB 7 Oral statement by Knowledge Ecology International 6… Continue Reading
Focused discussions on article 9 (Research and development) and article 11 (Transfer of technology and know-how) Monday,30 October 2023 15h30 UTC to 17h30 UTC 16h30 CET to 18h30 CET 11h30 EDT to 13h30 EDT On Monday, 30 October 2023, KEI… Continue Reading
The 154th session of the World Health Organization’s (WHO) Executive Board will take place from 22 January 2024 to 27 January 2024 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading
The USITC has issued a 497 page report on the WTO negotiations over TRIPS and COVID. https://www.usitc.gov/publications/332/pub5469.pdf The USITC release states: The U.S. International Trade Commission (USITC) today released a report about COVID-19 diagnostics and therapeutics and certain flexibilities under… Continue Reading